Published in Pol Tyg Lek on August 24, 1987
Renal replacement therapy in an era of socioeconomic changes--report from the Polish Registry. Nephrol Dial Transplant (1997) 1.39
Neural differentiation of pluripotent mouse embryonal carcinoma cells by retinoic acid: inhibitory effect of serum. Physiol Res (2005) 0.99
The influence of wine polyphenols on reactive oxygen and nitrogen species production by murine macrophages RAW 264.7. Physiol Res (2007) 0.97
The influence of propranolol on functional alterations of the electrocardiogram. Cardiologia (1968) 0.93
Eight-week, placebo-controlled, double-blind comparison of the antidepressant efficacy and tolerability of bupropion XR and venlafaxine XR. J Psychopharmacol (2008) 0.86
Uric acid modulates vascular endothelial function through the down regulation of nitric oxide production. Free Radic Res (2012) 0.84
[Usefulness of the Michigan Alcoholism Screening Test (MAST) in Poland]. Psychiatr Pol (1986) 0.84
Double-blind, placebo-controlled evaluation of extended-release bupropion in elderly patients with major depressive disorder. J Psychopharmacol (2009) 0.83
Carvedilol and adrenergic agonists suppress the lipopolysaccharide-induced NO production in RAW 264.7 macrophages via the adrenergic receptors. J Physiol Pharmacol (2009) 0.83
Controlled delivery of antimicrobial gallium ions from phosphate-based glasses. Acta Biomater (2008) 0.82
Comparative investigations of the influence of H1-antihistamines on the generation of reactive oxygen species by phagocytes. Inflamm Res (2008) 0.82
Surface characteristics and microbial adherence ability of modified polymethylmethacrylate by fluoridated glass fillers. Aust Dent J (2014) 0.82
Leukocyte mobilization, chemiluminescence response, and antioxidative capacity of the blood in intestinal ischemia and reperfusion. Free Radic Res (1997) 0.82
Total antioxidant capacity of serum increased in early but not late period after intestinal ischemia in rats. Free Radic Biol Med (1998) 0.82
Neural differentiation potentiated by the leukaemia inhibitory factor through STAT3 signalling in mouse embryonal carcinoma cells. Folia Biol (Praha) (2007) 0.81
[Tumor necrosis factor (TNF) and interleukin-6 (IL-6) in patients with glomerulonephritis]. Pol Arch Med Wewn (1996) 0.81
Ischemia/reperfusion injury of rat small intestine: the effect of allopurinol dosage. Transplant Proc (2001) 0.81
The effect of intestinal ischemia duration on changes in plasma antioxidant defense status in rats. Physiol Res (2004) 0.81
Blood phagocyte activation during open heart surgery with cardiopulmonary bypass. Physiol Res (2005) 0.80
New luminescence-based approach to measurement of luciferase gene expression reporter activity and adenosine triphosphate-based determination of cell viability. Folia Biol (Praha) (2010) 0.79
Vitreoretinal surgery in diabetic patients on hemodialysis. Eur J Ophthalmol (1998) 0.78
IL-10 does not affect oxidative burst and expression of selected surface antigen on human blood phagocytes in vitro. Physiol Res (2004) 0.77
Silkworm (Bombyx mori) hemocytes do not produce reactive oxygen metabolites as a part of defense mechanisms. Folia Microbiol (Praha) (2004) 0.76
The expression of NADPH oxidases and production of reactive oxygen species by human lung adenocarcinoma epithelial cell line A549. Folia Biol (Praha) (2010) 0.76
Antibiotic eluting clay mineral (Laponite®) for wound healing application: an in vitro study. J Mater Sci Mater Med (2014) 0.75
[Problems of the medical secret in forensic psychiatric certification - on the basis of analyses of 150 forensic psychiatric expert's opinions issued in penal cases (author's transl)]. Psychiatr Pol (1982) 0.75
Differential effects of v-Jun and c-Jun proteins on v-myb-transformed monoblasts. Cell Mol Life Sci (2002) 0.75
[T- and B-lymphocyte in chronic glomerulonephritis and uremia]. Pol Tyg Lek (1980) 0.75
[Results of two year use of dipyridamole and metindol in patients with primary focal and (or) segmental glomerulosclerosis]. Pol Merkur Lekarski (1997) 0.75
[Clinical experience with Sulprim]. Z Gesamte Inn Med (1977) 0.75
[Use of microcomputer technic in the hemodialysis department]. Pol Tyg Lek (1989) 0.75
[Ustimon (ST 7090) in the treatment of coronary disease]. Wiad Lek (1967) 0.75
[Antioxidative action of pyridoindoles and N-(alkoxyphenyl)-2-(2-oxo-1-aza-1-cycloalkyl) acetamides in biological, enzymatic and chemical systems]. Ceska Slov Farm (2003) 0.75
[AIDS-phobia as a symptom or psychopathologic syndrome]. Wiad Lek (1988) 0.75
Phagocyte-derived oxidants and plasma antioxidants in haemodialysed patients. Scand J Clin Lab Invest (2007) 0.75
[Combined treatment with hydrazinophthalazines and beta sympatholytic agents of nephrogenic hypertension]. Pol Tyg Lek (1976) 0.75
[Clinical study of the action of thioridazine-retard Polfa]. Psychiatr Pol (1972) 0.75
[Case of unusual orientation abilities (inborn capacity for localization of magnetic north pole)]. Psychiatr Pol (1982) 0.75
[Immune complexes and C3 and C4 of the complement in urine of patients with glomerulonephritis]. Pol Arch Med Wewn (1996) 0.75
Phagocyte-induced oxidative stress in patients with haemodialysis treatment and organ transplantation. Biofactors (1998) 0.75
[Ultrasound in parenchymatous diseases of the kidney]. Pol Tyg Lek (1989) 0.75
[20 episodes of acute non-inflammatory renal failure in acquired hemolytic anemia]. Pol Arch Med Wewn (1982) 0.75
[Arteriovenous fistulas for hemodialysis in patients with chronic renal failure]. Pol Przegl Chir (1977) 0.75
[Cellular immunity and the results of 2-year immunosuppressive treatment combined with the administration of dipyridamole and indomethacin in patients with chronic glomerulonephritis]. Pol Arch Med Wewn (1988) 0.75
[Various immunopathological phenomena and their role in the pathogenesis of glomerulonephritis]. Postepy Hig Med Dosw (1985) 0.75
[Anti-neutrophil cytoplasmic antibodies (ANCA) in the glomerulonephritis]. Pol Arch Med Wewn (1996) 0.75
A mini-review on novel intraperiodontal pocket drug delivery materials for the treatment of periodontal diseases. Drug Deliv Transl Res (2014) 0.75
[Autoantibodies against neutrophil cytoplasm and their significance in the classification of systemic vasculitis]. Przegl Lek (1995) 0.75
[Effect of antigen-antibody reaction on the blood clotting and fibrinolytic system]. Pol Arch Med Wewn (1976) 0.75
[Nephrocalcinosis in the course of multiple myeloma]. Wiad Lek (1968) 0.75
[Evaluation of a single infusion of low-molecular dextran in patients with chronic obliterative arterial diseases]. Pol Tyg Lek (1969) 0.75
[Case of ascites during treatment with repeated dialysis]. Pol Arch Med Wewn (1978) 0.75
[Protein polyacrylamide gel electrophoresis and level of neuraminic acids in cerebrospinal fluid in schizophrenics]. Pol Tyg Lek (1974) 0.75
[Use of ultrasound for evaluating structural changes of the renal parenchyma in chronic primary glomerulopathies]. Pol Tyg Lek (1990) 0.75
[Usefulness of the Cytur-Test in clinical practice]. Pol Tyg Lek (1986) 0.75
[Sorbonit in the treatment of coronary disease]. Wiad Lek (1968) 0.75
[Role of fibrinolytic activity in renal pathology]. Pol Tyg Lek (1975) 0.75
[Incidence of the occurrence of erythrocyte agglutinating antibodies coated with incomplete IgG or the products of their pepsin and papain digestion in chronic glomerulonephritis and dialysis patients]. Pol Arch Med Wewn (1982) 0.75
[Behavior of lipids in schizophrenics]. Pol Tyg Lek (1975) 0.75
[Metabolism of magnesium and lipid disturbances in chronic renal failure]. Pol Arch Med Wewn (1997) 0.75
[Case of oidiomycosis with unusual course]. Wiad Lek (1971) 0.75
[Studies on fibrinolysis in kidney diseases]. Pol Tyg Lek (1980) 0.75
[The role of cellular immunity in the pathogenesis of glomerulonephritis]. Postepy Hig Med Dosw (1989) 0.75
[Use of the low-molecular dextran for the treatment of thrombophlebitis]. Pol Przegl Chir (1969) 0.75
[Blood serum and urine levels of fibrin fibrinogen degradation products in kidney diseases]. Pol Tyg Lek (1980) 0.75